Grant: Banting Postdoctoral Fellowship Program
University of Toronto
$140,000.00
How do human cells regulate their death? Uncovering the molecular basis of apoptotic regulation
FY 2018-19
Summary
Human cells grow and proliferate under conditions of limited space and resources, and therefore must control their population to preserve balance. This is achieved through 'apoptosis', or programmed cell death. Such a powerful process requires exquisite control to prevent too much or too little cell death, as the dysregulation of apoptosis contributes to many human diseases. For instance, cancerous cells often proliferate uncontrollably and evade death by preventing apoptosis, rendering themselves resistant to chemotherapy. In neurodegenerative diseases, such as Alzheimer's or dementia, the massive and uncontrollable loss of neurons through apoptosis eventually leads to death. Canadian health care costs associated with cancer and Alzheimer's sum to nearly $30 billion, but the complex molecular origins of these diseases remain unclear, hindering the development of new therapies.
Apoptosis is carried out by proteins, nanometer-sized molecules that perform essential biological roles, often by interacting with other proteins. To understand apoptosis and its role in disease, proteins' three-dimensional structures and their dynamic web of interactions must be studied at the molecular level. Here, I aim to determine the molecular events that regulate apoptosis in humans. I will use cutting-edge biophysical methods to address two questions: how does the protein caspase-9 become activated to promote apoptosis, and how do the Hsp70 and Hsp90 proteins inhibit caspase-9 activation to prevent apoptosis? Both processes occur through presently unknown mechanisms, and yet significantly impact human health. For instance, caspase-9 activity has been used in immunotherapy, a promising new treatment for cancer, and many cancers exploit Hsp70 and Hsp90 to shut down apoptosis and evade death. Results from my research will provide critical insight that can be used to design drugs to disrupt or activate apoptosis as potential therapies for human diseases.
Department
Program
Banting Postdoctoral Fellowship Program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
394094
Name
Alderson Thomas R
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
How do human cells regulate their death? Uncovering the molecular basis of apoptotic regulation
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Apaf-1; Apoptosis; Apoptosome; Caspase; Hsp70; Hsp90; Molecular Chaperones; Nmr; Programmed Cell Death; Structural Biology
Abstract
Human cells grow and proliferate under conditions of limited space and resources, and therefore must control their population to preserve balance. This is achieved through 'apoptosis', or programmed cell death. Such a powerful process requires exquisite control to prevent too much or too little cell death, as the dysregulation of apoptosis contributes to many human diseases. For instance, cancerous cells often proliferate uncontrollably and evade death by preventing apoptosis, rendering themselves resistant to chemotherapy. In neurodegenerative diseases, such as Alzheimer's or dementia, the massive and uncontrollable loss of neurons through apoptosis eventually leads to death. Canadian health care costs associated with cancer and Alzheimer's sum to nearly $30 billion, but the complex molecular origins of these diseases remain unclear, hindering the development of new therapies.
Apoptosis is carried out by proteins, nanometer-sized molecules that perform essential biological roles, often by interacting with other proteins. To understand apoptosis and its role in disease, proteins' three-dimensional structures and their dynamic web of interactions must be studied at the molecular level. Here, I aim to determine the molecular events that regulate apoptosis in humans. I will use cutting-edge biophysical methods to address two questions: how does the protein caspase-9 become activated to promote apoptosis, and how do the Hsp70 and Hsp90 proteins inhibit caspase-9 activation to prevent apoptosis? Both processes occur through presently unknown mechanisms, and yet significantly impact human health. For instance, caspase-9 activity has been used in immunotherapy, a promising new treatment for cancer, and many cancers exploit Hsp70 and Hsp90 to shut down apoptosis and evade death. Results from my research will provide critical insight that can be used to design drugs to disrupt or activate apoptosis as potential therapies for human diseases.
Competitiondate
201809
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Alderson, Thomas R
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~